Literature DB >> 20837792

Vascular tumors of the iris in 45 patients: the 2009 Helen Keller Lecture.

Jerry A Shields1, Carlos Bianciotto, Brad E Kligman, Carol L Shields.   

Abstract

OBJECTIVE: To report on a series of vascular tumors of the iris.
DESIGN: Noncomparative case series. A retrospective medical record review of all patients with an iris vascular tumor was performed to identify the clinical features and develop a simple classification of these lesions. Included were demographics, clinical features, systemic associations, complications, management, and histopathology.
RESULTS: There were 54 eyes in 45 patients with an iris vascular tumor. These were categorized as racemose hemangioma (41 eyes: 29 simple and 12 complex), cavernous hemangioma (3 eyes: 2 localized and 1 systemic), capillary hemangioma (1 eye, localized), varix (3 eyes, localized), and microhemangiomatosis (6 eyes, localized). The hemangiomas occurred in adults at a median age of 55 years, whereas capillary hemangioma occurred in infancy and cavernous hemangioma with systemic involvement occurred in a child. Of the 41 eyes with iris racemose hemangioma, none showed systemic involvement. Of all 54 eyes, transient hyphema was the main complication, found at some point in 30% or more of each affected eye except for iris capillary and racemose hemangioma. Surgical resection was necessary in 1 cavernous hemangioma and 1 varix. The remainder were managed with observation.
CONCLUSIONS: There are now well-documented examples of iris racemose hemangioma, cavernous hemangioma, capillary hemangioma, varix, and microhemangiomatosis. Transient hyphema is the main complication. Observation is usually advised. Most are solitary lesions confined to the iris and some (cavernous hemangioma and microhemangiomatosis) can have important systemic associations.

Entities:  

Mesh:

Year:  2010        PMID: 20837792     DOI: 10.1001/archophthalmol.2010.188

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  [Unilateral tumor of the iris].

Authors:  A Ammermann; H Platzeck; H Hoerauf
Journal:  Ophthalmologe       Date:  2011-02       Impact factor: 1.059

2.  Optical Coherence Tomography Angiography Features of Iris Racemose Hemangioma in 4 Cases.

Authors:  Jason L Chien; Kareem Sioufi; Sandor Ferenczy; Emil Anthony T Say; Carol L Shields
Journal:  JAMA Ophthalmol       Date:  2017-10-01       Impact factor: 7.389

3.  Optical coherence tomography angiography of iris microhemangiomatosis.

Authors:  Amarjot S Kang; R Joel Welch; Kareem Sioufi; Emil Anthony T Say; Jerry A Shields; Carol L Shields
Journal:  Am J Ophthalmol Case Rep       Date:  2017-02-13

4.  Cell Phone Selfies: Clinching the Diagnosis of Iris Microhemangiomatosis.

Authors:  Kenneth W Price; John P Gorham; Jill R Wells
Journal:  Ocul Oncol Pathol       Date:  2021-04-01

Review 5.  Review of cystic and solid tumors of the iris.

Authors:  Carol L Shields; Patrick W Shields; Janet Manalac; Chaisiri Jumroendararasame; Jerry A Shields
Journal:  Oman J Ophthalmol       Date:  2013-09

6.  Spontaneous Hyphema from Iris Microhemangiomatosis in an Elderly Patient with Hypertensive Crisis.

Authors:  Pedro J Nuova; Dinah Zur; Anat Loewenstein; Matias Iglicki
Journal:  Case Rep Ophthalmol       Date:  2020-02-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.